ImmunityBio【IBRX】株式ニュース

名称	銘柄コード	市場	種別
ImmunityBio Inc	IBRX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.07	-0.90%	7.68	08:59:39

始値	安値	高値	終値	前日終値
7.77	7.54	8.068	7.65	7.75

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/17	22:00	BW	Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep..
2024/5/10	06:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/07	21:00	BW	ImmunityBio Completes GMP Drug Substance Manufacturing..
2024/5/03	05:04	BW	ImmunityBio, Serum Institute of India Agree on an Exclusive..
2024/4/30	21:00	BW	ImmunityBio Executive Chairman Dr. Patrick Soon-Shiong to..
2024/4/25	13:03	BW	ImmunityBio Announces Positive Overall Survival Results of..
2024/4/23	10:56	BW	ImmunityBio Announces FDA Approval of ANKTIVA®,..
2024/3/06	23:00	BW	NIAID-Sponsored Study Shows N-803 Combined with Neutralizing..
2024/3/05	23:00	BW	N-803 Combined with Natural Killer Cells Showed Potential to..
2024/2/27	06:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/27	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/27	06:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/24	11:28	EDGAR2	Form 8-K - Current report
2024/2/21	23:00	BW	ImmunityBio Announces Full Accrual of First Two Phases of..
2024/2/07	11:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/05	23:00	BW	ImmunityBio Quality-of-Life Study in BCG-Unresponsive..
2024/2/03	09:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	09:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/04	11:59	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2024/1/04	11:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/04	11:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/02	20:08	EDGAR2	Form 8-K - Current report
2024/1/02	20:00	BW	ImmunityBio Announces $320 Million Investment by Oberland..
2023/11/16	23:00	BW	ImmunityBio to Participate in 35th Annual Piper Sandler..
2023/11/09	11:28	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07	23:00	BW	First Data for ImmunityBio’s Memory Cytokine-Enriched NK..
2023/10/27	01:03	DJN	ImmunityBio Shares Rally as FDA Accepts N-803 Resubmission
2023/10/26	22:00	BW	FDA Accepts ImmunityBio’s BLA Resubmission as Complete and..
2023/10/24	00:00	DJN	ImmunityBio Shares 11% Higher on License Application..
2023/10/23	22:00	BW	ImmunityBio Announces Biological License Application..
2023/9/28	19:06	EDGAR2	Form DEF 14C - Other definitive information statements
2023/9/23	04:06	EDGAR2	Form D - Notice of Exempt Offering of Securities
2023/9/22	05:25	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2023/9/11	19:25	EDGAR2	Form 8-K - Current report
2023/9/11	19:00	BW	ImmunityBio Announces $470 Million Equity and Debt Financing..
2023/9/07	08:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/07	08:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/01	21:30	EDGAR2	Form 8-K - Current report
2023/8/29	18:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/8/29	10:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/29	09:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/22	18:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/8/16	18:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/8/16	05:15	EDGAR2	Form 8-K - Current report
2023/8/11	18:45	PRNUS	IBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio..
2023/8/09	18:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/8/09	05:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/04	18:45	PRNUS	IBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio..
2023/8/03	22:00	BW	ImmunityBio Names Enrique Diloné as Chief Technology Officer
2023/8/02	18:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..